date:Sep 12, 2012
ts suggest a significant benefit to L. reuteri prophylaxis in this subset of neonates.
The authors note that the study was partially funded through a grant from BioGaia Inc, though the researchers declare they have no competing interests.
Study details
The study analysed data from 311 premature infants, born with a weight below 1000 grams.
The groups are separated into those neonates born from January 2004 to June 30, 2009, before introduction of L. reuteri, and neonates born July 2009 throu